Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
2,622.85
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
1,000.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,622.85
2,177.41
1,852.14
1,490.84
1,376.18
1,134.21
1,000.07
Raw Material Cost
753.02
667.70
612.97
540.67
419.76
371.33
412.06
Purchase of Finished goods
574.48
444.28
314.78
163.25
311.57
120.60
105.85
(Increase) / Decrease In Stocks
-183.76
-73.86
-6.39
12.90
-136.28
52.95
-19.90
Employee Cost
350.30
293.64
239.37
220.30
197.32
168.42
159.07
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
596.12
387.07
352.09
294.84
244.20
228.66
210.86
Total Expenditure (Excl Depreciation)
2,090.16
1,718.83
1,512.82
1,231.96
1,036.58
941.96
867.93
Operating Profit (PBDIT) excl Other Income
532.69
458.58
339.32
258.88
339.60
192.25
132.14
Other Income
66.33
50.42
59.31
41.85
6.69
0.33
4.62
Operating Profit (PBDIT)
599.02
509.00
398.63
300.73
346.29
192.58
136.76
Interest
11.66
11.20
9.13
8.45
7.99
8.75
9.66
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
587.36
497.80
389.50
292.28
338.30
183.83
127.10
Depreciation
83.39
74.27
51.85
44.78
36.15
26.66
22.80
Profit Before Tax
503.97
423.53
337.65
247.51
302.16
157.17
104.31
Tax
121.35
108.63
72.33
60.70
63.63
36.42
23.87
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
382.62
314.90
265.32
186.81
238.54
120.75
80.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
382.62
314.90
265.32
186.81
238.54
120.75
80.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.04
-1.20
0.99
-2.25
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
380.58
313.70
266.31
184.57
238.54
120.75
80.44
Equity Capital
45.32
45.32
45.32
40.93
40.93
40.93
40.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,421.60
2,019.74
1,699.85
1,161.34
845.56
595.08
501.55
Earnings per share (EPS)
8.4
6.92
5.88
4.51
5.83
2.95
1.97
Diluted Earnings per share
8.4
6.92
6.41
4.51
5.76
2.86
1.87
Operating Profit Margin (Excl OI)
20.31%
21.06%
18.32%
17.36%
24.68%
16.95%
13.21%
Gross Profit Margin
22.39%
22.86%
21.03%
19.61%
24.58%
16.21%
12.71%
PAT Margin
14.59%
14.46%
14.33%
12.53%
17.33%
10.65%
8.04%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 20.46% vs 17.56% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 21.32% vs 17.80% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 16.16% vs 35.15% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 4.11% vs 22.67% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Marksans Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,622.85
0
2,622.85
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,622.85
0
2,622.85
Raw Material Cost
753.02
0
753.02
Purchase of Finished goods
574.48
0
574.48
(Increase) / Decrease In Stocks
-183.76
0
-183.76
Employee Cost
350.30
0
350.30
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
596.12
0.00
596.12
Total Expenditure (Excl Depreciation)
2,090.16
0
2,090.16
Operating Profit (PBDIT) excl Other Income
532.69
0.00
532.69
Other Income
66.33
0
66.33
Operating Profit (PBDIT)
599.02
0
599.02
Interest
11.66
0
11.66
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
587.36
0
587.36
Depreciation
83.39
0
83.39
Profit Before Tax
503.97
0
503.97
Tax
121.35
0
121.35
Provisions and contingencies
0.00
0
0.00
Profit After Tax
382.62
0
382.62
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
382.62
0
382.62
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-2.04
0
-2.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
380.58
0
380.58
Equity Capital
45.32
0
45.32
Face Value
1.00
0
0.00
Reserves
2,421.60
0
2,421.60
Earnings per share (EPS)
8.40
0
8.40
Diluted Earnings per share
8.40
0
8.40
Operating Profit Margin (Excl OI)
20.31%
0%
0.00
20.31%
Gross Profit Margin
22.39%
0%
0.00
22.39%
PAT Margin
14.59%
0%
0.00
14.59%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,622.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 20.46% vs 17.56% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 380.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.32% vs 17.80% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 532.69 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.16% vs 35.15% in Mar 2024
Annual - Interest
Interest 11.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.11% vs 22.67% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.31%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
